Synthesis and biological activities of novel 17-aminogeldanamycin derivatives

Bioorganic & Medicinal Chemistry
Zong-Qiang TianDavid Myles

Abstract

Geldanamycin interferes with the action of heat shock protein 90 (Hsp90) by binding to the N-terminal ATP binding site and inhibiting an essential ATPase activity. In a program directed toward finding potent, water soluble inhibitors of Hsp90, we prepared a library of over sixty 17-alkylamino-17-demethoxygeldanamycin analogs, and compared their affinity for Hsp90, ability to inhibit growth of SKBr3 mammalian cells, and in selected cases, water solubility. Over 20 analogs showed cell growth inhibition potencies similar to that of 17-allylamino-17-demethoxygeldanamycin (17-AAG), the front-runner geldanamycin analog that is currently in multiple clinical trials. Many of these analogs showed water solubility properties that were desirable for formulation. One of the most potent and water-soluble analogs in the series was 17-(2-dimethylaminoethyl)amino-17-demethoxygeldanamycin (17-DMAG), which was independently prepared by the NCI and will soon enter clinical trials. Importantly, the binding affinity of these analogs to the molecular target Hsp90 does not correlate well with their cytotoxicity in SKBr3 cells.

References

Jan 1, 1995·Cancer Chemotherapy and Pharmacology·J G SupkoL Malspeis
Jan 5, 2002·Expert Opinion on Biological Therapy·Alison Maloney, Paul Workman
Apr 5, 2003·Cancer Cell·Jennifer S IsaacsLen Neckers
Oct 8, 2003·Current Cancer Drug Targets·Paul Workman
Oct 8, 2003·Current Cancer Drug Targets·Chrisostomos Prodromou, Laurence H Pearl
Oct 8, 2003·Current Cancer Drug Targets·Edward A SausvillePercy Ivy

❮ Previous
Next ❯

Citations

Apr 26, 2007·Pharmaceutical Research·Ying HuangWolfgang Sadée
Mar 31, 2005·Biochemical and Biophysical Research Communications·Eran BarzilayDrorit Neumann
Jul 3, 2007·Nature Chemical Biology·Anna RodinaGabriela Chiosis
Mar 4, 2011·Proceedings of the National Academy of Sciences of the United States of America·Qian XieGeorge F Vande Woude
Jan 9, 2010·The Journal of Pharmacology and Experimental Therapeutics·Rosemary A NdoloJeffrey P Krise
Apr 7, 2005·Applied and Environmental Microbiology·Leandro VetcherZhihao Hu
Jul 16, 2010·Journal of Oncology·J E BohonowychJ S Isaacs
Jul 18, 2008·Cancer Research·Takeshi ShimamuraGeoffrey I Shapiro
Jul 19, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Takeshi ShimamuraGeoffrey I Shapiro
Mar 25, 2006·Future Oncology·Chengkai Dai, Luke Whitesell
Mar 29, 2014·Journal of Biotechnology·Emilia SchaxCarsten Zeilinger
Mar 29, 2014·Expert Opinion on Investigational Drugs·Komal JhaveriGabriela Chiosis
Jun 27, 2008·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Takeshi Shimamura, Geoffrey I Shapiro
Jun 7, 2014·Chemical Biology & Drug Design·Zhenyu LiYuemao Shen
Apr 23, 2010·Current Opinion in Chemical Biology·James R PorterKristopher M Depew
May 5, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ho-Chul ShinGlen S Kwon
Nov 24, 2007·Current Opinion in Biotechnology·Ming-Qiang Zhang, Barrie Wilkinson
Jul 31, 2007·Journal of Molecular Biology·S C OnuohaS E Jackson
Jan 2, 2007·Biochemical and Biophysical Research Communications·Shin-ichiro NakagawaMichinori Kohara
Oct 15, 2010·British Journal of Pharmacology·Martin McLaughlin, Koen Vandenbroeck
Jun 16, 2011·Biotechnology Progress·Micheal Whelehan, Ian W Marison
Jun 29, 2015·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Matthew Trendowski
Nov 23, 2005·Expert Opinion on Therapeutic Targets·Angela D Hamblin, Terry J Hamblin
Feb 15, 2015·Cancer Chemotherapy and Pharmacology·Yan-ping LiZhuo-rong Li
Dec 22, 2004·Chemistry & Biology·Kedar PatelRobert McDaniel
Apr 1, 2014·Journal of Biological Rhythms·Rebecca SchneiderHans Reinke
Sep 8, 2016·International Journal of Radiation Biology·Colin Rae, Robert J Mairs
Apr 12, 2008·Angewandte Chemie·Justin K Belardi, Glenn C Micalizio
Sep 17, 2008·Oncogene·C Garcia-Echeverria, W R Sellers
Aug 18, 2009·ChemMedChem·Miriam Sgobba, Giulio Rastelli

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.